Gemfos 35mg Tablet belongs to the therapeutic classification of . The primary composition for this medicine is Risedronate 35 MG.

Gemfos Tablet 4's is not advised in persons who have problems with the oesophagus, or low calcium levels in their blood. After taking this medicine, a person should sit upright or stand for at least half an hour; otherwise, it can cause serious stomach or oesophagus problems. Gemfos Tablet 4's can increase the risk of jaw bone problems (osteonecrosis), especially in those treated with steroids, chemotherapy, radiation, cancer, blood cell disorders, and pre-existing dental problems. Gemfos Tablet 4's is only an only part of a complete program that includes diet modification, regular exercise, bone mineral density testing, and consuming calcium and vitamin supplements. A person should consult with their doctor's if they ever had trouble swallowing, problems with your stomach or digestion, hypocalcemia, a dental problem (you may need a dental exam before you begin taking alendronate), kidney disease; or any condition that makes it hard for your body to absorb nutrients from food (malabsorption) before taking this medicine. Pregnant ladies should first consult with their doctor before taking Gemfos Tablet 4's as it is not known whether this medicine will harm an unborn baby. Breastfeeding women should first consult with the doctor before taking Gemfos Tablet 4's to pass into breast milk and affect the infant.